Barclays Maintains Overweight on Eli Lilly, Raises Price Target to $1550
Benzinga Newsdesk 22 hours ago
Analyst RatingsNewsPrice TargetHot
This page contains a summary, not the full article. Continue to benzinga.com to read the original report.
Barclays analyst Emily Field maintains Eli Lilly (NYSE:LLY) with a Overweight and raises the price target from $1400 to $1550.
Barclays analyst Emily Field maintains Eli Lilly (NYSE:LLY) with a Overweight and raises the price target from $1400 to $1550.
